This Biotech Company Has Spent Nearly 3 Years in FDA Limbo
The FDA says it can't license Regenative Lab's overseas sales today because it might change its regulations tomorrow. Now, the company is suing.
The FDA says it can't license Regenative Lab's overseas sales today because it might change its regulations tomorrow. Now, the company is suing.
Joe Rogan and military veterans advocating for suicide prevention apparently swayed the president.
An immigrant's journey to the radical left and back
AI doctors are bringing affordable medical care to Utah. Skeptics are now trying to slow it down.
That total is a low-ball estimate because some federal agencies didn't report their totals to the Government Accountability Office.
Vermont passed single-payer legislation in 2011 and abandoned the plan after three years of failure. Why?
Eli Lilly's retatrutide is a significant advance on the promising results from drugs like Ozempic and Wegovy.
Arizona Democrats are calling for a full investigation and transparency after a medical examiner concluded Emmanuel Damas died from a severe tooth infection.
Roth explains why legalizing kidney sales can save lives.
And the government's "solution" is making it worse.
The administration's goal to lower prices is a good one, but officials don't actually have a plan to make it happen.
Families have complained for years that the Bureau of Prisons fails to notify them when their incarcerated loved ones are seriously ill or even dying.
Plus: Trump’s budget ignores the deficit, NASA’s Artemis program faces delays and rising costs, and a listener asks about libertarian alternatives to Medicare for All.
"It shouldn't be this hard to give birth safely in the state of Alabama, and it doesn't have to," said the ACLU's lead counsel on the case.
From charging patients for black market drugs to providing medically unnecessary treatments, fraudsters have been gaming Medicare and Medicaid for decades.
While he admits New York is facing a “serious fiscal crisis,” Mamdani’s solutions won’t actually fix it.
The state's funding crisis is driven by a third-party payment system in which roughly 90 cents of every American health care dollar is paid by someone other than the patient.
His push relies on dubious data about the pills' safety.
The employer insurance exclusion has chained workers to their employers, practically eliminated consumer price sensitivity, and suppressed wages.
A new bill could make Maryland "the most restrictive environment in the country," warns one doctor.
The legal exploitation of Medicaid's federal matching system is a much bigger problem than criminal fraud.
A federal judge ruled in 2022 that "no legitimate humane system would operate" like Arizona's prison health care system. Three years later, that same judge found the problems still hadn't been fixed.
Price controls and regulatory burdens make the market unattractive for pharmaceutical companies.
A system that allows drug makers to profit from restricted access will never liberalize on its own—and patients will continue to bear the cost.
The Break Up Big Medicine Act makes no mention of the laws and government programs responsible for consolidation of the health care industry.
Delphi-2M was trained on the world's most comprehensive biomedical database with health information from over 400,000 people.
Federal authorities should not be able to turn civil commitment into a life sentence for anyone the government deems inconvenient.
It seems likely the FDA would do well to accept more Bayesian reasoning in medical research.
A new film tells the story of a cancer patient’s quest to confront the existential angst of dying by taking magic mushrooms.
A new film tells the story of a cancer patient’s quest to confront the existential angst of dying by taking magic mushrooms.
Zohran Mamdani had a chance to pursue health care reform in the New York State Assembly. He didn’t take it.
AI-powered medical wearables and software are flourishing following the FDA’s new regulatory guidance.
Is Medical Aid in Dying a fundamental right? Or a slippery slope toward state-supported suicide?
Plus: Threats of new tariffs on NATO allies, masked federal agents stir unrest in Minnesota, and Trump’s new health care proposal.
I didn’t really understand the power of Medical Aid in Dying until I received my terminal diagnosis.
Empowering patients is good. Let’s give them a lot more choice and independence.
The real squeeze comes from government-distorted markets, not economic decline.
Frederick Bardell died from treatable colon cancer after waiting six months for a colonoscopy.
While Europe and Asia have had Stellest glasses for years, the FDA finally approved them for the U.S. in 2025.
“Free” healthcare costs a lot in personal time and taxpayer money.
It's also not the whole story. Federal spending isn't falling and the private sector job market is stagnant.
A real affordability agenda would unleash free markets, not constrain them.
Celebrate your independence with a subscription to Reason magazine, your most trusted source of honest, insightful news and analysis.